CEL-SCI (CVM) to Raise $5.60 Million in Registered Direct Offering  
6/19/2012 10:16:01 AM

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, has entered into a definitive agreement to sell 16,000,000 shares of its common stock at a price per share of $0.35 pursuant to a registered direct offering to an institutional investor, representing gross proceeds of approximately $5.60 million.